Literature DB >> 30075313

Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis.

J E J Buckman1, A Underwood2, K Clarke2, R Saunders2, S D Hollon3, P Fearon2, S Pilling2.   

Abstract

PURPOSE: To review and synthesise prognostic indices that predict subsequent risk, prescriptive indices that moderate treatment response, and mechanisms that underlie each with respect to relapse and recurrence of depression in adults. RESULTS AND
CONCLUSIONS: Childhood maltreatment, post-treatment residual symptoms, and a history of recurrence emerged as strong prognostic indicators of risk and each could be used prescriptively to indicate who benefits most from continued or prophylactic treatment. Targeting prognostic indices or their "down-stream" consequences will be particularly beneficial because each is either a cause or a consequence of the causal mechanisms underlying risk of recurrence. The cognitive and neural mechanisms that underlie the prognostic indices are likely addressed by the effects of treatments that are moderated by the prescriptive factors. For example, psychosocial interventions that target the consequences of childhood maltreatment, extending pharmacotherapy or adapting psychological therapies to deal with residual symptoms, or using cognitive or mindfulness-based therapies for those with prior histories of recurrence. Future research that focuses on understanding causal pathways that link childhood maltreatment, or cognitive diatheses, to dysfunction in the neocortical and limbic pathways that process affective information and facilitate cognitive control, might result in more enduring effects of treatments for depression.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Depression; Depressive disorder; Major; Recurrence; Review; Risk factors

Mesh:

Year:  2018        PMID: 30075313      PMCID: PMC6237833          DOI: 10.1016/j.cpr.2018.07.005

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  87 in total

Review 1.  Recognition and management of depression in general practice: consensus statement.

Authors:  E S Paykel; R G Priest
Journal:  BMJ       Date:  1992-11-14

2.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

3.  Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.

Authors:  Zindel V Segal; Sidney Kennedy; Michael Gemar; Karyn Hood; Rebecca Pedersen; Tom Buis
Journal:  Arch Gen Psychiatry       Date:  2006-07

4.  Rumination and social problem-solving in depression.

Authors:  Ed Watkins; Simona Baracaia
Journal:  Behav Res Ther       Date:  2002-10

5.  Prediction of the three-year course of recurrent depression in primary care patients: different risk factors for different outcomes.

Authors:  Henk Jan Conradi; Peter de Jonge; Johan Ormel
Journal:  J Affect Disord       Date:  2007-06-14       Impact factor: 4.839

6.  Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse.

Authors:  L L Judd; H S Akiskal; J D Maser; P J Zeller; J Endicott; W Coryell; M P Paulus; J L Kunovac; A C Leon; T I Mueller; J A Rice; M B Keller
Journal:  J Affect Disord       Date:  1998-09       Impact factor: 4.839

7.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

8.  Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

Authors:  F Hardeveld; J Spijker; R De Graaf; W A Nolen; A T F Beekman
Journal:  Psychol Med       Date:  2012-10-31       Impact factor: 7.723

Review 9.  Can long-term treatment with antidepressant drugs worsen the course of depression?

Authors:  Giovanni A Fava
Journal:  J Clin Psychiatry       Date:  2003-02       Impact factor: 4.384

Review 10.  Double trouble: does co-morbid chronic somatic illness increase risk for recurrence in depression? A systematic review.

Authors:  Gemma D Kok; Claudi L H Bockting; Huibert Burger; Wiebke Hannig; Gerdina H M Pijnenborg; Pim Cuijpers; Steven D Hollon
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more
  60 in total

1.  Euthymia: why it really does matter.

Authors:  Andrew MacLeod
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

2.  Dispositional negativity, cognition, and anxiety disorders: An integrative translational neuroscience framework.

Authors:  Juyoen Hur; Melissa D Stockbridge; Andrew S Fox; Alexander J Shackman
Journal:  Prog Brain Res       Date:  2019-04-17       Impact factor: 2.453

3.  Predicting and preventing relapse of depression in primary care.

Authors:  Andrew S Moriarty; Joanne Castleton; Simon Gilbody; Dean McMillan; Shehzad Ali; Richard D Riley; Carolyn A Chew-Graham
Journal:  Br J Gen Pract       Date:  2020-01-30       Impact factor: 5.386

4.  Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.

Authors:  Tina Pahlevan; Christine Ung; Zindel Segal
Journal:  Can J Psychiatry       Date:  2020-02-07       Impact factor: 4.356

5.  Digital solutions for shaping mood and behavior among individuals with mood disorders.

Authors:  Amanda Victory; Allison Letkiewicz; Amy L Cochran
Journal:  Curr Opin Syst Biol       Date:  2020-07-23

6.  Roles of sedative-hypnotics in patients with recurrent major depressive disorder: a nationwide population-based 14-year follow-up study in Taiwan.

Authors:  Kuo-Hsuan Chung; Tzu-Yin Lee; Min-Huey Chung
Journal:  Psychopharmacology (Berl)       Date:  2021-02-25       Impact factor: 4.530

7.  Do Cognitive Therapy Skills Neutralize Lifetime Stress to Improve Treatment Outcomes in Recurrent Depression?

Authors:  Jeffrey R Vittengl; Sonja Stutzman; Aparna Atluru; Robin B Jarrett
Journal:  Behav Ther       Date:  2019-11-27

8.  Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.

Authors:  Andrew S Moriarty; Nicholas Meader; Kym Ie Snell; Richard D Riley; Lewis W Paton; Carolyn A Chew-Graham; Simon Gilbody; Rachel Churchill; Robert S Phillips; Shehzad Ali; Dean McMillan
Journal:  Cochrane Database Syst Rev       Date:  2021-05-06

Review 9.  Large-Scale Transcriptomics Studies Provide Insight Into Sex Differences in Depression.

Authors:  Marianne L Seney; Jill Glausier; Etienne Sibille
Journal:  Biol Psychiatry       Date:  2021-01-08       Impact factor: 13.382

10.  The Relationship of Post-traumatic Stress Disorder to End-of-life Care Received by Dying Veterans: a Secondary Data Analysis.

Authors:  Kathleen E Bickel; Richard Kennedy; Cari Levy; Kathryn L Burgio; F Amos Bailey
Journal:  J Gen Intern Med       Date:  2019-12-02       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.